靶向c-Abl与β1整合素增强头颈癌细胞放射敏感性
该研究在8种实体瘤细胞系的3D层粘连蛋白富集ECM培养中,联合β1整合素抗体AIIB2与c-Abl抑制剂伊马替尼并联合X线照射,发现部分细胞系出现高于单药的放射增敏,DNA修复受损可能参与其中,外源过表达c-Abl可削弱该增敏效应。
要点
- AIIB2联合伊马替尼在部分实体瘤细胞系中产生高于单药的放射增敏。
- 该增敏可能与DNA修复受损相关,外源过表达c-Abl可削弱增敏。
- c-Abl磷酸化状态或可作为伊马替尼辅助放化疗的参考指标。
核心结论
- 在3D癌症细胞培养模型中,c-Abl是β1整合素下游影响放射抵抗和DNA修复的进一步决定因素。
- 对于实体瘤,c-Abl磷酸化状态可能提示伊马替尼作为常规放化疗辅助的合理应用。
研究设计与样本
- 研究在8种不同实体瘤细胞系的3D层粘连蛋白富集ECM培养中进行,联合使用β1整合素单抗AIIB2与c-Abl抑制剂伊马替尼并联合或不联合X线照射。
- 检测指标包括克隆源性存活、残余DNA双链断裂、蛋白表达与磷酸化。
主要发现
- AIIB2与伊马替尼单用或联用产生细胞系依赖的细胞毒性。
- 部分细胞系对AIIB2/伊马替尼联合的放射增敏程度高于两种单药治疗。
- 在该亚组中,放射反应与磷酸化c-Abl Y412之间呈非统计学显著趋势。
- AIIB2/伊马替尼的放射增敏可能与DNA修复受损相关。
- 外源过表达野生型或组成性激活型c-Abl可削弱AIIB2/伊马替尼相关放射增敏。
关键数值与推荐
- 靶向β1整合素使用AIIB2单克隆抗体,靶向c-Abl使用伊马替尼,联合或不联合X线照射。
- 在8种实体瘤细胞系中评估克隆源性存活、残余DNA双链断裂、蛋白表达与磷酸化。
临床怎么用
- c-Abl磷酸化状态或可作为实体瘤中伊马替尼辅助常规放化疗的参考指标。
- β1整合素与c-Abl双靶向联合放疗的增敏策略需在更接近生理的3D培养模型中进一步验证。
局限性
- 放射反应与磷酸化c-Abl Y412之间的趋势未达统计学显著。
- 研究基于3D癌症细胞培养模型,非临床或体内研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Integrin-mediated cell adhesion to extracellular matrix (ECM) critically contributes to cancer cell therapy resistance and DNA double strand break (DSB) repair. c-Abl tyrosine kinase has been linked to both of these processes. Based on our previous findings indicating c-Abl hyperphosphorylation on tyrosine (Y) 412 and threonine (T) 735 upon beta1-integrin inhibition, we hypothesized c-Abl tyrosine kinase as an important mediator of beta1-integrin signaling for radioresistance. In a panel of 8 cell lines from different solid cancer types grown in 3D laminin-rich ECM cultures, we targeted beta1 integrin with AIIB2 (mAb) and c-Abl with Imatinib with and without X-ray irradiation and subsequently examined clonogenic survival, residual DSBs, protein expression and phosphorylation. Single or combined treatment with AIIB2 and Imatinib resulted in cell line-dependent cytotoxicity. Intriguingly, we identified a subgroup of this cell line panel that responded with a higher degree of radiosensitization to AIIB2/Imatinib relative to both single treatments. In this subgroup, we observed a non-statistically significant trend between the radioresponse and phospho-c-Abl Y412. Mechanistically, impairment of DNA repair seems to be associated with radiosensitization upon AIIB2/Imatinib and AIIB2/Imatinib-related radiosensitization could be reduced by exogenous overexpression of either wildtype or constitutively active c-Abl forms relative to controls. Our data generated in more physiological 3D cancer cell culture models suggest c-Abl as further determinant of radioresistance and DNA repair downstream of beta1-integrin. For solid cancers, c-Abl phosphorylation status might be an indicator for reasonable Imatinib application as adjuvant for conventional radio(chemo)therapy.
引用
- Koppenhagen P, Dickreuter E, Cordes N, et al. Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin. Radiother Oncol. 2017. PMID: 28578803. doi:10.1016/j.radonc.2017.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。